The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid. 2018

Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
Department of Chemistry, Innovative Drug Research Center, College of Sciences, Shanghai University, Shanghai 200444, China.

A series of N-sulfonaminoethyloxime derivatives of dehydroabietic acid were synthesized and investigated for their antibacterial activity against Staphylococcus aureus Newman strain and multidrug-resistant strains (NRS-1, NRS-70, NRS-100, NRS-108 and NRS-271). Most of the target compounds having chloro, bromo, trifluoromethyl phenyl moiety exhibited potent in vitro antistaphylococcal activity. The meta-CF3 phenyl derivative T23 showed the highest activity with MIC of 0.39-0.78 μg/mL against S. aureus Newman, while several analogues showed similar potent antibacterial activity with MIC values between 0.78 and 1.56 μg/mL against five multidrug-resistant S. aureus. The stability of T35 in plasma of SD rat and the cellular cytotoxicity were also evaluated.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D045784 Abietanes A subclass of cyclical DITERPENES that contain the abietane ring structure. Abietane Diterpene,Abietane Diterpenoid,Abietane Diterpenoids,Diterpenes, Abietane,Isopimarane,Isopimaranes,Totarane Diterpene,Totarane Diterpenes,Totaranes,Diterpenes, Pimarane,Pimaranes,Abietane Diterpenes,Diterpene, Abietane,Diterpene, Totarane,Diterpenoid, Abietane,Pimarane Diterpenes
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
November 2016, Bioorganic & medicinal chemistry letters,
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
February 2017, European journal of medicinal chemistry,
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
January 2016, Bioorganic & medicinal chemistry letters,
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
April 2012, Molecules (Basel, Switzerland),
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
April 1985, Chemical & pharmaceutical bulletin,
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
February 2010, European journal of medicinal chemistry,
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
February 2014, Molecules (Basel, Switzerland),
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
February 2017, Molecules (Basel, Switzerland),
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
September 2007, Journal of microbiological methods,
Wen-Ming Zhang, and Yang Yao, and Teng Yang, and Xue-Ying Wang, and Zhen-Yun Zhu, and Wen-Tao Xu, and Hai-Xia Lin, and Zhao-Bing Gao, and Hu Zhou, and Cai-Guang Yang, and Yong-Mei Cui
October 2013, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!